Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides

Keith Henry Moss, Petya Popova, Sine Reker Hadrup, Kira Astakhova*, Maria Taskova

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review


Gene therapy is an exciting field that has the potential to address emerging scientific and therapeutic tasks. RNA-based gene therapy has made remarkable progress in recent decades. Nevertheless, efficient targeted delivery of RNA therapeutics is still a prerequisite for entering the clinics. In this review, we introduce current delivery methods for RNA gene therapeutics based on lipid nanoparticles (LNPs). We focus on the clinical appeal of recent RNA NPs and discuss existing challenges of fabrication and screening LNP candidates for effective translation into drugs of human metabolic diseases and cancer.
Original languageEnglish
JournalMolecular Pharmaceutics
Issue number6
Pages (from-to)2265-2277
Publication statusPublished - 2019


  • Gene therapy
  • RNA
  • Delivery
  • Lipid nanoparticle (LNP)
  • LNP fabrication
  • LNP screening


Dive into the research topics of 'Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides'. Together they form a unique fingerprint.

Cite this